hpv16 e7 peptide-pulsed autologous dcs
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2003 (NCT00155766)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hpv16 e7 peptide-pulsed autologous dcs
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03870113 | Phase 1 | Apr 1, 2019 | Shenzhen University |
| NCT00155766 | Phase 1 | Jan 1, 2003 | National Taiwan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Taiwan University | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Shenzhen University | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1